Screener
PTC Therapeutics PTCT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
FAQ
- What is PTC Therapeutics's current ratio?
- PTC Therapeutics (PTCT) reported current ratio of 2.4× in Q1 2026.
- How has PTC Therapeutics's current ratio changed year-over-year?
- PTC Therapeutics's current ratio decreased by 37.3% year-over-year, from 3.9× to 2.4×.
- What is the long-term trend for PTC Therapeutics's current ratio?
- Over 5 years (2020 to 2025), PTC Therapeutics's current ratio has grown at a -12.0% compound annual growth rate (CAGR), from 4.4× to 2.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about PTC Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude